Tomio Narisawa
- Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress 8
- Cancer Research top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Drug Transport and Resistance Mechanisms 7
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 10
- Nutrition and Dietetics top 5%
-
- Gastric Cancer Management and Outcomes 10
-
- Helicobacter pylori-related gastroenterology studies 9
-
- Cancer Research and Treatments 7
-
- Genetic factors in colorectal cancer 7
- Co-authors
- John H. WeisburgerErnst L. WynderBandaru S. ReddyJ. H. WeisburgerYoko FukauraE. L. WynderMakiko HasebeMasanori Sano
- Cited by
- BiochemistryCancer ResearchOncology
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Cancer (4 papers)Carcinogenesis (3 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Tomio Narisawa
66 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biochemistry 291
- Cancer Research 585
- Oncology 797
- Pharmacology 400
- Nutrition and Dietetics 244
Countries citing papers authored by Tomio Narisawa
This map shows the geographic impact of Tomio Narisawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomio Narisawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomio Narisawa more than expected).
Fields of papers citing papers by Tomio Narisawa
This network shows the impact of papers produced by Tomio Narisawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomio Narisawa. The network helps show where Tomio Narisawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomio Narisawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 16 | |
| 2 | 2002 | 19 | |
| 3 | 2000 | 117 | |
| 4 | 1999 | 9 | |
| 5 | 1999 | 29 | |
| 6 | 1996 | 118 | |
| 7 | 1996 | 59 | |
| 8 | 1994 | 62 | |
| 9 | 1994 | 81 | |
| 10 | 1992 | 23 | |
| 11 | 1991 | 0 | |
| 12 | 1991 | 12 | |
| 13 | 1990 | 55 | |
| 14 | 1988 | 6 | |
| 15 | Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. | 1980 | 80 |
| 16 | Cancer chemotherapy model using autochthonous large bowel cancer in rats. | 1978 | 7 |
| 17 | 1975 | 22 | |
| 18 | Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. | 1975 | 153 |
| 19 | [Clinical and pathological observations on 193 cases of colonic cancer--with reference to symptoms and pathological findings]. | 1967 | 1 |
| 20 | 1965 | 3 |
About Tomio Narisawa
Tomio Narisawa is a scholar working on Biochemistry, Biochemistry and Biotechnology, having authored 70 papers that have together received 2.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), Inflammatory mediators and NSAID effects (10 papers), Helicobacter pylori-related gastroenterology studies (9 papers), Colorectal Cancer Treatments and Studies (8 papers), Antioxidant Activity and Oxidative Stress (8 papers), Cancer Research and Treatments (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Biochemistry (291 citations), Cancer Research (585 citations) and Oncology (797 citations). Tomio Narisawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include John H. Weisburger, Ernst L. Wynder, Bandaru S. Reddy, J. H. Weisburger, Yoko Fukaura, E. L. Wynder, Makiko Hasebe, Masanori Sano, Ching-Quo Wong and Hoyoku Nishino. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.